FLNA

0.638714.05%
GL

Grant L. Schoenhard

Member of Scientific Advisory Board

Dr. Grant L. Schoenhard, Ph.D., served as Independent Consultant of Pain Therapeutics Inc. from October 31, 2014 to October 31, 2015 and served as its Chief Scientific Officer from September 2001 to October 31, 2014. Dr. Schoenhard joined Filana Therapeutics, Inc. (formerly known as Cassava Sciences, Inc.) (formerly known as Pain Therapeutics, Inc.) in September 2000 as its Vice President of Preclinical Development. From February 2000 to September 2000, Dr. Schoenhard served as a Consultant and provided pharmacodynamic research and development services to various organizations. From September 1998 to February 2000, Dr. Schoenhard served as a Senior Director of Pharmacokinetics, Drug Metabolism and Pharmacology at Genentech, Inc. From 1974 to July 1998, Dr. Schoenhard held various management positions, including Executive Director of Pharmacokinetics, Drug Metabolism and Radiochemistry at Searle, a pharmaceutical company owned by Monsanto Corporation. Dr. Schoenhard served as a Member of the Board of Directors of LC Resources, Inc. from December 1998 to January 2002. Dr. Schoenhard was Adjunct Professor of Pharmacology, School of Medicine, University of Pennsylvania for a number of years. Dr. Schoenhard holds a BS from Michigan State University and an MS and Ph.D from Oregon State University.

Positions